CRH's dividend is seen as sustainable, backed by profit and cash flow. Its growing earnings and low payout ratios hint at a promising long-term dividend stock. The firm's consistent dividend and earnings growth show a commitment to rewarding shareholders.
Despite lower than expected Q4 numbers, investors are not worried due to the company's positive outlook for 2024, driven by significant infrastructure investment and re-industrialization activity across key markets in North America and Europe.
The strong EPS growth and insider buying at CRH indicate a positive outlook for the company. The growth rate and insider activity suggest that the company could be a good investment opportunity.
The market's view of CRH has improved over the last five years, likely due to consistent earnings growth. Recent insider buying and strong share price momentum suggest potential investment opportunities.
CRH's dividend is sustainable unless earnings drop sharply, as it's backed by profit and cash flow. A low payout ratio and quick earnings per share growth hint a focus on reinvestment. Over the past decade, dividends increased by around 5.2% annually, less than earnings per share growth. CRH's business growth prospects suggest enticing future dividends.
CRH plc is seen as undervalued, with its positive outlook and expected earnings growth hinting at a good time for shareholders to accumulate more holdings. The current share price may not fully mirror the promising future, presenting a potential buying opportunity for investors.
Even from work I could tell that was a wild day. I wish I could've been posting updates at open as my buy callshad a decent day Iam going to do things differently again. I'll chart QQQ first on a short time frame to highlight how money moves. Then the Dollar, 10yr Treasury, Gold, VIX, and Oil to show 3 possible outcomes from tomorrow's FED meeting. The charts have a lot of triangles ready to break. I'll end by charting futures of Oil, Silver, VIX, and NQ $納指100ETF-Invesco QQQ Trust(QQQ.US)$The volu...
Gainers: •$Checkmate Pharmaceuticals(CMPI.US)$+331.5% (Regeneron Pharma (REGN) to acquire CMPI for $10.50/share in cash) •$Axsome Therapeutics(AXSM.US)$+27.9% (received and agreed to Postmarketing Requirements/Commitments proposed by the FDA with respect to the New Drug Application for its AXS-05 product candidate for the treatment of major depressive disorder) •$超微電腦(SMCI.US)$+14.3% (earnings report) •$普拉格能源(PLUG.US)$+9.24% (t...
CRH水泥股票討論區
Gap Ups
1. $韓國電力(KEP.US)$ - up 7.39%
2. $DocuSign(DOCU.US)$ - up 5.58%
3. $洲際酒店(IHG.US)$ - up 3%
4. $韓國友利金融(WF.US)$ - up 2.78%
5. $韓國國民銀行(KB.US)$ - up 2.34%
6. $奈飛(NFLX.US)$ - up 2.28%
7. $新韓金融(SHG.US)$...
CRH水泥是2006年上市的愛爾蘭企業,主要市場在美國,歐洲和英國,目前價格35。毛利率5年來基本在34%左右波動。公司上市以來一直保持分紅,股息率TTM為3.3%。
看財報時注意,公司在2020年之前的財報都是以歐元計價。
近5年來營收波動中上升了25%,營業利潤除2020年下滑22.8%之外增長了4年,5年平均增長率為15.5%,淨利潤則是在2019年大幅下降40.5%,2020年又下降35%。
翻看原始財報可以看出,2018年有13.9億的停止經營業務利潤,刨除這部分影響,2019年淨利潤也是增長的。2020年則是由於營業利潤下滑引起的,而營業利潤下滑則是由於營收略微下滑的情況下費用大幅增加引起的。
2021年營收、營業利潤和淨利潤分別增加12.3%,75%和129%。2022Q1官網顯示營收增長13%。
資產負債率5年來從53%上升到59%後,又降回了53%。應收帳款和存貨分別佔營收的15%和12%,比例都不算高。長期貸款99億,佔淨資產的50%,利息費用佔營業利潤的8.7%,負擔還可以。
近5年來,除2017年,經營現金流都大幅超...
I wish I could've been posting updates at open as my buy calls had a decent day
Iam going to do things differently again. I'll chart QQQ first on a short time frame to highlight how money moves.
Then the Dollar, 10yr Treasury, Gold, VIX, and Oil to show 3 possible outcomes from tomorrow's FED meeting. The charts have a lot of triangles ready to break. I'll end by charting futures of Oil, Silver, VIX, and NQ
$納指100ETF-Invesco QQQ Trust(QQQ.US)$ The volu...
• $Checkmate Pharmaceuticals(CMPI.US)$ +331.5% (Regeneron Pharma (REGN) to acquire CMPI for $10.50/share in cash)
• $Axsome Therapeutics(AXSM.US)$ +27.9% (received and agreed to Postmarketing Requirements/Commitments proposed by the FDA with respect to the New Drug Application for its AXS-05 product candidate for the treatment of major depressive disorder)
• $超微電腦(SMCI.US)$ +14.3% (earnings report)
• $普拉格能源(PLUG.US)$ +9.24% (t...
暫無評論